Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reaction was having a dry mouth.
Most common adverse reactions during the study
28.8 μg GP MDI 
14.4 μg GP MDI 
7.2 μg GP MDI 
Placebo 
Spiriva Respimat
Adverse
(out of 235 participants) 
Dry mouth 0.9% (2)
Headache 0.9% (2)
Loss of voice 0.4% (1)
Infection of the main airways of the lungs 0.0% (0)
Sore throat 0.0% (0)
Chest discomfort 0.0% (0)